L-alanosine

DRUG2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)

Conditions

Brain and Central Nervous System TumorsLung CancerMalignant MesotheliomaPancreatic CancerSarcoma

Phase 1

Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas

CompletedNCT00075894

National Cancer Institute (NCI)Brain and Central Nervous System Tumors

Start: 2004-03-31Target: 18Updated: 2009-01-13

Phase 2

Alanosine in Treating Patients With Cancer

CompletedNCT00062283

Memorial Sloan Kettering Cancer CenterLung Cancer, Malignant Mesothelioma, Pancreatic Cancer +1

Start: 2003-03-31End: 2009-12-31Updated: 2013-06-26